Search Medical Condition
Please enter condition
Please choose location from dropdown

Oulu, Finland Clinical Trials

A listing of Oulu, Finland clinical trials actively recruiting patients volunteers.

RESULTS

Found (77) clinical trials

Operative Correction of Rectus Muscle Diastasis (ARD): the Effect on Low Back Pain and Movement Control

Abdominal diastasis recti (ADR) persists after pregnancies in one third of women. Traditionally plain ADR has been managed conservatively. There is some evidence that ADR reduces abdominal integrity and functional strength, contributing to pelvic instability and back pain. However, patients are referred to a surgeon mainly because of some other ...

Phase N/A

0.0 miles

Learn More »

Synthetic vs Natural Estrogen in Combined Oral Contraception

The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of ...

Phase

0.0 miles

Learn More »

Outcome After Coronary Artery Bypass Grafting

Improvements in the surgical treatment of coronary artery disease are possible only when implementation of current methods and development of new methods are based on the solid ground of large and reliable clinical data. Furthermore, clinical findings assume even more significance when detected in study populations from different institutions with ...

Phase N/A

0.0 miles

Learn More »

A Study of Perioperative Oral Nutritional Support for Patients Having Surgery for Colon Cancer Peri-Nutri

The hypothesis in this study are: Preoperative ONS may decrease surgery related morbidity at the group of patients with NRS 3 or more. Preoperative ONS may increase the quality of life after surgery in patients with NRS 3 or more Preoperative ONS may decrease the length of the hospital stay ...

Phase N/A

0.0 miles

Learn More »

An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)

This is a longitudinal observational study of the relationship between measures of -cell function, genotype, immunological phenotype and potential environmental factors over time, in individuals with new onset T1D or first degree relatives at higher risk for T1D due to the presence of auto-antibodies. It is a multicentre international study ...

Phase N/A

0.0 miles

Learn More »

Extremely Low Gestatonal Age Infants' Paracetamol Study

The purpose of this randomized, placebo-controlled, double-blind, phase 2, one center clinical trial is to study the efficacy and safety of early (< 96 h) intravenous paracetamol in prophylactic closure of ductus arteriosus in extremely premature (gestational age <28+0 wk, ELGA) or low birth weight (<1000 g, ELBW) infants. The ...

Phase

0.0 miles

Learn More »

Paracetamol And Ibuprofen in Closing Patent Ductus Arteriosus

Premature infants (born before 37 weeks gestational age) with paptent ductus arteriosus (PDA) are the focus of the study since no trials on the additive efficacy of these two medications on the contraction of ductus arteriosus are available. Preterm infants who are diagnosed to have a hemodynamically significant PDA and ...

Phase

0.0 miles

Learn More »

Estimation of the Minimal Important Difference and Validation of Foot and Ankle Instruments

Patients who are waiting for foot and ankle surgery are recruited from four large referral centers (Peijas Hospital, Seinjoki Central Hospital, Central Finland Central Hospital, Oulu University Hospital). Participants fill in foot and ankle-specific, generic and sosiodemographic questionnaires on the day of surgery, 6 months after surgery, and 6 months ...

Phase N/A

0.0 miles

Learn More »

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

This Nordic Myeloma Study Group study is phase 2 study for newly diagnosed transplant eligible myeloma patients between 18 - 70 years of age. Patients will have four IRd cycles of 28 day each as induction consisting of ixazomib 4 mg on days 1, 8 and 15 and lenalidomide 25 ...

Phase

0.0 miles

Learn More »

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

MIN-117C03 is a 6-week, 3-arm, randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of MIN-117 in male and female patients with Major Depressive Disorder, aged 18 to 65 years. Approximately 324 patients will be randomly assigned to 1 of 3 treatment arms, including placebo, 5.0 mg MIN-117, or ...

Phase

0.0 miles

Learn More »